A biosensor is a device that detects specific biological or chemical substances by combining a biological recognition element with an electronic detector. It works like a molecular alarm system: one part identifies the target substance, another converts that recognition event into a measurable signal, and a third processes that signal into a readable result. The concept dates back to 1962, when the first enzyme electrode converted glucose into a detectable electrical current. Today, biosensors power everything from home glucose monitors to environmental water testing.
How a Biosensor Works
Every biosensor has three core components working in sequence. The first is the bioreceptor, the biological material that physically interacts with whatever substance you’re trying to detect (called the analyte). The bioreceptor is what gives a biosensor its specificity. Just as a lock only accepts one key, the bioreceptor binds to or reacts with only its target molecule, ignoring everything else in the sample.
The second component is the transducer. Once the bioreceptor latches onto its target, that interaction causes a tiny physical change, a shift in electrical charge, a change in light absorption, a difference in mass. The transducer picks up that change and converts it into an electrical signal. The third component, the signal processor, amplifies that electrical signal, filters out noise, and translates it into something useful: a number on a screen, a color change, or a positive/negative result.
Types of Bioreceptors
The biological recognition element is the heart of any biosensor, and researchers have a growing toolkit to choose from. Enzymes are among the most common. They work by capturing and chemically converting a target molecule into a measurable product, a process called biocatalysis. Glucose test strips, for example, use an enzyme that breaks down glucose and generates an electrical current proportional to the sugar concentration.
Antibodies provide another approach. These naturally occurring proteins bind to a specific target (their antigen) with extremely high accuracy, forming a lock-and-key pair. Antibody-based biosensors are the backbone of many rapid diagnostic tests, including pregnancy tests and infectious disease kits. Nucleic acid biosensors, sometimes called genosensors, exploit the way DNA strands pair with complementary sequences. By immobilizing a known DNA fragment on the sensor surface, the device can detect when a matching genetic sequence from a pathogen or mutation binds to it.
Beyond these natural molecules, newer synthetic options are expanding what biosensors can do. Aptamers are short, lab-designed DNA or RNA strands that fold into shapes capable of binding not just other nucleic acids but also proteins, small molecules, metal ions, and even whole cells. Molecularly imprinted polymers (MIPs) take a completely artificial route, using a plastic-like matrix molded around the target molecule so it fits back in like a puzzle piece. These synthetic receptors are cheaper to produce and more stable than biological ones, making them attractive for harsh environments.
How Signals Get Converted
The transducer type determines what kind of physical change the biosensor actually measures, and different applications call for different approaches.
- Electrochemical transducers measure changes in electrical current or voltage when the bioreceptor interacts with its target. They’re the most widely used type, providing rapid outputs often within minutes. The original glucose biosensor worked this way, and modern continuous glucose monitors still rely on this principle.
- Optical transducers detect changes in light, whether that’s absorption, fluorescence, or the way light bends at a surface. Detection times typically range from 5 to 30 minutes. These sensors are common in lab diagnostics and are increasingly being miniaturized for portable use.
- Piezoelectric transducers respond to changes in mass. When target molecules bind to the sensor surface, the added weight shifts the vibration frequency of a crystal element. These can deliver results in under 10 minutes and are used for detecting pathogens and toxins.
- Thermal transducers measure the heat generated or absorbed during a biochemical reaction. They’re less common but useful when the target reaction produces a reliable temperature change.
Medical Applications
Healthcare is the largest application area for biosensors. The medical segment held the biggest share of the global biosensor market in 2025, with point-of-care testing alone accounting for roughly 40% of end-user demand. The appeal is straightforward: biosensors can deliver lab-quality results at the bedside, in a doctor’s office, or at home.
Continuous glucose monitors (CGMs) are the most familiar example. These small sensors sit just under the skin and measure glucose levels in the fluid between cells, sending readings to a phone or receiver every few minutes. In outpatient settings, modern CGMs achieve an overall accuracy (measured as mean absolute relative difference, or MARD) close to 10%, meaning the sensor reading typically falls within 10% of a standard blood test. For hospital use, experts recommend aiming for a MARD below 14%.
Rapid infectious disease testing is another major area. During the COVID-19 pandemic, biosensor-based rapid antigen tests became a household item. In research settings, biosensors have demonstrated detection of SARS-CoV-2 at concentrations as low as about 4,000 genome copies per milliliter. Across different infectious diseases, point-of-care biosensors generally return results in 5 to 30 minutes, compared to hours or days for traditional lab tests. A piezoelectric immunosensor for tularemia antibodies, for instance, delivers results in under 10 minutes. A nanowire-based sensor for Ebola virus proteins completes a test in roughly 3 to 5 minutes.
Environmental and Food Safety Testing
Biosensors are increasingly used to detect pesticides, heavy metals, and other contaminants in water and food. The advantage over traditional lab analysis is portability and speed: a biosensor can be brought to a river, a well, or a processing plant and deliver on-site results.
Detection limits have become remarkably sensitive. An enzyme-based biosensor designed to spot the pesticide paraoxon in tap water achieved a detection limit of 0.5 nanomolar, an incredibly tiny concentration. Aptamer-based sensors have detected the herbicide paraquat at 16.5 micrograms per liter. An engineered yeast-based biosensor can identify the fungicide tebuconazole in natural water samples at just 5 micrograms per liter. These devices work by measuring how much a pesticide inhibits or interacts with the biological recognition element. When chlorpyrifos is present in seawater or wastewater, for example, a whole-cell biosensor using engineered bacteria can flag it at concentrations as low as 5 nanomolar.
This kind of sensitivity matters because many pesticides are harmful at very low levels, and traditional detection methods require expensive equipment and trained technicians. Biosensors bring that capability to the field.
Wearable Biosensors
The next frontier is biosensors built into wearable devices that continuously track health markers through sweat, tears, or interstitial fluid. Most commercial wearable biosensors today focus on glucose, but research is pushing into a much wider range of biomarkers.
Stress monitoring is one active area. Most existing wearable sensors can only measure cortisol, the body’s primary long-term stress hormone, and only at a single point in time. That misses the full picture, because acute stress events are driven by a different class of hormones: epinephrine and norepinephrine (the “fight or flight” chemicals). A recently developed wearable called Stressomic uses a microfluidic chip to simultaneously track cortisol, epinephrine, and norepinephrine in sweat. By measuring all three in real time, it can distinguish between acute and chronic stress, something a cortisol-only sensor cannot do.
Lactate monitoring during exercise, electrolyte tracking for hydration, and even alcohol detection through sweat are all being explored in wearable formats. The technical challenge is miniaturizing the components, keeping the bioreceptor stable against body heat and sweat chemistry, and ensuring accuracy outside of controlled lab conditions.
Key Performance Metrics
When evaluating any biosensor, four metrics matter most. Sensitivity refers to the device’s ability to correctly identify a substance when it’s present: a highly sensitive biosensor produces very few false negatives. Specificity is the flip side, the ability to correctly return a negative result when the target isn’t there, meaning few false positives. The limit of detection (LOD) is the lowest concentration of a substance the biosensor can reliably distinguish from a blank sample. And response time is how quickly the device delivers a result after the sample is applied.
These metrics interact with each other. A biosensor with an extremely low LOD might sacrifice speed, and a very fast sensor might be less specific. The best device for a given task depends on the context. A screening test for a deadly infection prioritizes sensitivity (you don’t want to miss cases), while a confirmatory test prioritizes specificity (you don’t want false alarms).
Market Growth and Adoption
The global biosensor market was valued at approximately $32.6 billion in 2025 and is projected to reach about $35.5 billion by 2026, with growth expected to continue toward $74.8 billion by 2035. The primary drivers are the rising prevalence of chronic diseases like diabetes and cardiovascular disease, government initiatives promoting early screening and disease detection, and the expanding field of portable medical devices. Point-of-care testing remains the dominant use case, reflecting the broader shift in healthcare toward faster, decentralized diagnostics that don’t require a central laboratory.